I agree that this site is using cookies. You can find further informations here.
X
Hájek, Roman
633  results:
Search for persons X
?
1

Nivolumab, Pomalidomide, and Elotuzumab Combination Regimen..:

Oriol, Albert ; Hájek, Roman ; Spicka, Ivan...
Clinical Lymphoma Myeloma and Leukemia.  , 2024
Link: https://doi.org/10.1016/..
 
?
2

International Myeloma Working Group immunotherapy committee..:

Rodriguez-Otero, Paula ; Usmani, Saad ; Cohen, Adam D...
The Lancet Oncology.  25 (2024)  5 - p. e205-e216 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Healthcare Resource Utilization and Cost-of-Illness in Syst..:

Jaccard, Arnaud ; Bridoux, Frank ; Roeloffzen, Wilfried...
Clinical Lymphoma Myeloma and Leukemia.  , 2024
Link: https://doi.org/10.1016/..
 
?
4

Use Via Early Access to Ixazomib (UVEA-IXA) Study: Effectiv..:

Ludwig, Heinz ; Ramasamy, Karthik ; Mateos, María-Victoria...
Clinical Lymphoma Myeloma and Leukemia.  24 (2024)  2 - p. e40-e49.e3 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Immunoablative therapy followed by autologous hematopoietic..:

Lachnit, Martin ; Revendova, Kamila Zondra ; Hradilek, Pavel...
Biomedical Papers.  168 (2024)  1 - p. 50-54 , 2024
Link: https://doi.org/10.5507/..
 
?
6

Ixazomib plus daratumumab and dexamethasone: Final analysis..:

Delimpasi, Sosana ; Dimopoulos, Meletios A. ; Straub, Jan...
American Journal of Hematology.  , 2024
Link: https://doi.org/10.1002/..
 
?
7

P-042 Early infections in myeloma patients treated with ant..:

Radocha, Jakub ; Pour, Ludek ; Jelinek, Tomas...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S57-S58 , 2023
Link: https://doi.org/10.1016/..
 
?
8

P805: EXTRAMEDULLARY MULTIPLE MYELOMA: MOLECULAR PATHOGENES..:

Zihala, David ; Jelinek, Tomas ; Sevcikova, Tereza...
HemaSphere.  7 (2023)  S3 - p. e003730a , 2023
Link: https://doi.org/10.1097/..
 
?
9

P-344 Multiomics profiling of extramedullary multiple myelo..:

Jelinek, Tomas ; Zihala, David ; Sevcikova, Tereza...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S228-S229 , 2023
Link: https://doi.org/10.1016/..
 
?
10

Effectiveness of tixagevimab/cilgavimab in patients with he..:

Demel, Ivo ; Skopal, David ; Šafránková, Eliška...
Annals of Hematology.  103 (2023)  3 - p. 981-992 , 2023
Link: https://doi.org/10.1007/..
 
?
11

Separation of Isomeric Tau Phosphopeptides from Alzheimer's..:

Kováč, Andrej ; Majerová, Petra ; Nytka, Marianna...
Journal of the American Society for Mass Spectrometry.  34 (2023)  3 - p. 394-400 , 2023
Link: https://doi.org/10.1021/..
 
?
12

P832: PROSPECTIVE REAL-WORLD EVALUATION OF THE PREVALENCE O..:

Gavriatopoulou, Maria ; Spencer, Andrew ; Coriu, Daniel...
HemaSphere.  7 (2023)  S3 - p. e9381810 , 2023
Link: https://doi.org/10.1097/..
 
?
13

Prevention and management of adverse events during treatmen..:

Ludwig, Heinz ; Terpos, Evangelos ; van de Donk, Niels...
The Lancet Oncology.  24 (2023)  6 - p. e255-e269 , 2023
Link: https://doi.org/10.1016/..
 
?
14

Benefit Versus Risk Assessment of Melflufen and Dexamethaso..:

Sonneveld, Pieter ; Richardson, Paul G. ; Ludwig, Heinz...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  9 - p. 687-696 , 2023
Link: https://doi.org/10.1016/..
 
?
15

P-159 Lenalidomide maintenance in R2-ISS stratified multipl..:

Radocha, Jakub ; Jungova, Alexandra ; Pour, Ludek...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S122-S123 , 2023
Link: https://doi.org/10.1016/..
 
1-15